Therefore, Fas expression was assessed in P, NP and IUGR women and we showed no significant difference in expression within PBMCs, lymphocytes, CD4+ or CD8+ T-cells between any of the patient cohorts (Supplementary Fig. 2). The gene discussed is CD8A; the disease is fetal growth restriction.